Research graph
References from The Pediatric Opioid Overdose and Addiction Crisis. Local targets link to admitted publications; unresolved targets remain external evidence.
Current causes of death in children and adolescents in the United States
10.1056/nejmc2201761 · 2022 · External reference
Drug overdose deaths among persons aged 10–19 years - United States, July 2019-December 2021
10.15585/mmwr.mm7150a2 · 2022 · External reference
Trends in seizures of powders and pills containing illicit fentanyl in the United States, 2018 through 2021
10.1016/j.drugalcdep.2022.109398 · 2022 · External reference
The impact of the COVID-19 pandemic on adolescent mental health and substance use
10.1016/j.jadohealth.2022.05.025 · 2022 · External reference
The changing landscape of adolescent and young adult substance use
10.1016/j.jadohealth.2024.07.024 · 2024 · External reference
#Drugsforsale: an exploration of the use of social media and encrypted messaging apps to supply and access drugs
10.1016/j.drugpo.2018.08.005 · 2019 · External reference
Predictors of using social media to purchase drugs in New Zealand: findings from a large-scale online survey
10.1016/j.drugpo.2021.103430 · 2021 · External reference
Effective parenting interventions to reduce youth substance use: a systematic review
10.1542/peds.2015-4425 · 2016 · External reference
Family-focused universal substance use prevention in primary care: advancing a pragmatic national healthcare agenda
10.1007/s11121-023-01584-4 · 2024 · External reference
Standard versus family-based screening, brief intervention, and referral to treatment for adolescent substance use in primary care: protocol for a multisite randomized effectiveness trial
10.2196/54486 · 2024 · External reference
Parent-focused prevention of adolescent health risk behavior: study protocol for a multisite cluster-randomized trial implemented in pediatric primary care
10.1016/j.cct.2021.106621 · 2022 · External reference
Association between substance use diagnoses and psychiatric disorders in an adolescent and young adult clinic-based population
10.1016/j.jadohealth.2016.12.018 · 2017 · External reference
Substance use prevalence, patterns, and correlates in transgender and gender diverse youth: a scoping review
10.1016/j.drugalcdep.2023.110880 · 2023 · External reference
Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: the adverse childhood experiences study
10.1542/peds.111.3.564 · 2003 · External reference
A developmental cascade model for early adolescent-onset substance use: the role of early childhood stress
10.1111/add.14452 · 2019 · External reference
Adolescent-serving addiction treatment facilities in the United States and the availability of medications for opioid use disorder
10.1016/j.jadohealth.2020.03.005 · 2020 · External reference
Adolescent residential addiction treatment in the US: uneven access, waitlists, and high costs
10.1377/hlthaff.2023.00777 · 2024 · External reference
Treatments used among adolescent residential addiction treatment facilities in the US, 2022
10.1001/jama.2023.6266 · 2023 · External reference
Age of cannabis use onset and adult drug abuse symptoms: a prospective study of common risk factors and indirect effects
10.1177/0706743718760289 · 2018 · External reference
Opioid prescribing for acute pain management in children and adolescents in outpatient settings: clinical practice guideline
10.1542/peds.2024-068752 · 2024 · External reference
Trends in drug overdose deaths among US adolescents, January 2010 to June 2021
10.1001/jama.2022.2847 · 2022 · External reference
Socioeconomic risk factors for fatal opioid overdoses in the United States: findings from the Mortality Disparities in American Communities Study (MDAC)
10.1371/journal.pone.0227966 · 2020 · External reference
How the war on drugs impacts social determinants of health beyond the criminal legal system
10.1080/07853890.2022.2100926 · External reference
Association of racial/ethnic segregation with treatment capacity for opioid use disorder in counties in the United States
10.1001/jamanetworkopen.2020.3711 · 2020 · External reference
Disparities in treatment for substance use disorders and co-occurring disorders for ethnic/racial minority youth
10.1016/j.jaac.2010.10.005 · 2011 · External reference
Receipt of addiction treatment after opioid overdose among Medicaid-enrolled adolescents and young adults
10.1001/jamapediatrics.2019.5183 · 2020 · External reference
Receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder
10.1001/jamapediatrics.2018.2143 · 2018 · External reference
Age at drinking onset and alcohol dependence: age at onset, duration, and severity
10.1001/archpedi.160.7.739 · 2006 · External reference
Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study
10.1111/j.1360-0443.2007.02015.x · 2007 · External reference
Unresolved reference
2017 · External reference
Viewing our adolescent patients through a positive lens
2007 · External reference
Unresolved reference
2016 · External reference
Unresolved reference
External reference
Testing for drugs of abuse in children and adolescents
10.1542/peds.2014-0865 · 2014 · External reference
Urine toxicology test for children with altered mental status
10.1542/peds.2022-060861 · 2023 · External reference
Appropriate use of drug testing in clinical addiction medicine
10.1097/adm.0000000000000323 · 2017 · External reference
The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update
2020 · External reference
Appropriate Use of Drug Testing in Clinical Addiction Medicine
External reference
ASAM Criteria Course - 4th Edition Development
External reference
Provider and practice characteristics and perceived barriers associated with different levels of adolescent SBIRT implementation among a national sample of US pediatricians
10.1177/00099228211034334 · 2021 · External reference
Adolescent SBIRT practices among pediatricians in Massachusetts
10.1097/adm.0000000000000551 · 2020 · External reference
Adolescent substance use screening in primary care: validity of computer self-administered versus clinician-administered screening
10.1080/08897077.2015.1014615 · 2016 · External reference
Confidentiality in the care of adolescents: policy statement
10.1542/peds.2024-066326 · 2024 · External reference
Confidential healthcare for adolescent minors and young adults: a position paper of the Society for Adolescent Health and Medicine
10.1016/j.jadohealth.2025.06.006 · 2025 · External reference
Stigma associated with medication treatment for young adults with opioid use disorder: a case series
10.1186/s13722-018-0116-2 · 2018 · External reference
Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review
10.1016/j.drugalcdep.2013.02.018 · 2013 · External reference
Recommended terminology for substance use disorders in the care of children, adolescents, young adults, and families
10.1542/peds.2022-057529 · 2022 · External reference
10.17226/25310
10.17226/25310 · 2019 · External reference
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
10.1136/bmj.j1550 · 2017 · External reference
Mortality during and following treatment with extended-release naltrexone based on data from two clinical trials
10.1016/j.drugalcdep.2025.112737 · 2025 · External reference
Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis
10.1001/jamapsychiatry.2021.0976 · 2021 · External reference
Medication-assisted treatment of adolescents with opioid use disorders
10.1542/peds.2016-1893 · 2016 · External reference
Medication for adolescents and young adults with opioid use disorder
10.1016/j.jadohealth.2020.12.129 · 2021 · External reference
Medications for maintenance treatment of opioid use disorder in adolescents: a narrative review and assessment of clinical benefits and potential risks, offering a public health perspective-a commentary on Camenga et al
10.15288/jsad.2019.80.403 · 2019 · External reference
The Clinical Opiate Withdrawal Scale (COWS)
10.1080/02791072.2003.10400007 · 2003 · External reference
Two new rating scales for opiate withdrawal
10.3109/00952998709001515 · 1987 · External reference
Racial and ethnic disparities in mental health care for children and young adults: a national study
10.1177/0020731416662736 · 2016 · External reference
Explaining racial/ethnic differences in adolescent substance abuse treatment completion in the United States: a decomposition analysis
10.1016/j.jadohealth.2014.01.002 · 2014 · External reference
Training in adolescent substance and opioid misuse in pediatric residency programs
10.1542/peds.2021-053423 · 2022 · External reference
Treating adolescent opioid use disorder in primary care
10.1001/jamapediatrics.2023.6493 · 2024 · External reference
Management of opioid misuse and opioid use disorders among youth
10.1542/peds.2019-2056c · 2020 · External reference
Community reinforcement and family training: an effective option to engage treatment-resistant substance-abusing individuals in treatment
10.1111/j.1360-0443.2010.03016.x · 2010 · External reference
“A peer support worker can really be there supporting the youth throughout the whole process”: a qualitative study exploring the role of peer support in providing substance use services to youth
10.1186/s12954-023-00853-3 · 2023 · External reference
SMART recovery for youth: a small, exploratory qualitative study examining the potential of a mutual-aid, peer support addictive behaviour change program for young people
10.1186/s13722-023-00379-w · 2023 · External reference
YPR-Young People In Recovery
2025 · External reference
Principles of care for young adults with co-occurring psychiatric and substance use disorders
10.1542/peds.2020-023523f · 2021 · External reference
Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis
10.1136/bmj.f174 · 2013 · External reference
Naloxone expansion is not associated with increases in adolescent heroin use and injection drug use: evidence from 44 US states
10.1016/j.drugpo.2023.103980 · 2023 · External reference
Opioid-overdose laws association with opioid use and overdose mortality
10.1016/j.addbeh.2018.03.014 · 2018 · External reference
Anticipatory guidance to prevent adolescent overdoses
10.1542/peds.2023-065217 · 2024 · External reference
Unresolved reference
External reference
Pediatricians’ role in overdose prevention: a call for universal naloxone dispensing
10.1542/peds.2024-067258 · 2024 · External reference
Addressing adolescent substance use with a public health prevention framework: the case for harm reduction
10.1080/07853890.2022.2104922 · External reference
Developing harm reduction in the context of youth substance use: insights from a multi-site qualitative analysis of young people’s harm minimization strategies
10.1186/s12954-017-0180-z · 2017 · External reference
Transition to adulthood for youth with chronic conditions and special health care needs
10.1016/j.jadohealth.2020.02.006 · 2020 · External reference
Buprenorphine treatment duration and adherence among youth and subsequent health outcomes
10.1542/peds.2025-071147 · 2025 · External reference
Defining and operationalizing the phenomena of recovery: a working definition from the recovery science research collaborative
10.1080/16066359.2018.1515352 · 2019 · External reference
“My life isn’t defined by substance use”: recovery perspectives among young adults with substance use disorder
10.1007/s11606-021-06934-y · 2022 · External reference
Sensitivity and specificity of S2BI for identifying alcohol and cannabis use disorders among adolescents presenting for primary care
10.1080/08897077.2020.1803180 · 2021 · External reference
Substance Use Screening, Brief Intervention, and Referral to Treatment
10.1542/peds.2016-1211 · 2016 · External reference
Validity of brief screening instrument for adolescent tobacco, alcohol, and drug use
10.1542/peds.2013-2346 · 2014 · External reference
Validity of the CRAFFT substance abuse screening test among adolescent clinic patients
10.1001/archpedi.156.6.607 · 2002 · External reference
Screening adolescents for nicotine dependence: the Hooked On Nicotine Checklist
10.1016/s1054-139x(03)00531-7 · 2004 · External reference
Validation and performance of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) among adolescent primary care patients
10.1111/add.12767 · 2015 · External reference
10.1176/appi.books.9780890425596
10.1176/appi.books.9780890425596 · 2013 · External reference
Opioid Use Disorder: Diagnosis
2024 · External reference
A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults
10.1111/add.13363 · 2016 · External reference
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial
10.1016/s0140-6736(17)32812-x · 2018 · External reference
Buprenorphine dose and time to discontinuation among patients with opioid use disorder in the era of fentanyl
10.1001/jamanetworkopen.2023.34540 · 2023 · External reference
